Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    19144941 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
Latino Study - A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) and COPEGUS (Ribavirin) in Treatment-Naive Patients With Chronic Hepatitis C-Genotype 1.
Condition: Hepatitis C, Chronic
Interventions: Drug: Ribavirin;   Drug: Peginterferon alfa-2a

Indicates status has not been verified in more than two years